InnaMed (YC W17)

InnaMed - Origin Story🌱

founder @ InnaMed (YC W17)

Published on Apr 6, 2021

The Beginning...💡

  • Eshwar and Anup met through Dr. David Issadore, whose laboratory combines microelectronics, microfluidics, and nanomaterials to create miniaturized platforms for the diagnosis of disease🔬
  • They founded InnaMed while  students at the University of Pennsylvania🎓
  • The company was initially founded as a direct to consumer business aiming to make monitoring nutrition and wellness easier for the average person💊

Attending Y Combinator 🚀

  • InnaMed was accepted to Y Combinator in Winter, 2017✔️
  • The company was advised by Jared Friedman (co-founder of Scribd) and Paul Buchheit (creator of Gmail, co-founder of FriendFeed)👨‍🏫
  • The company pivoted from a direct to consumer business model to a B2B model focused on chronic disease management and pharma industries↩️
  • After Demo Day, InnaMed raised $1M for product development 💲

Licensing the Technology⚡

    • InnaMed’s blood testing technology was first developed by Dr. Christopher Easley’s lab at Auburn University🧫
    • Dr. Easley is funded by the NIH and NSF. He has 40+ publications and patents in microfluidics & bio-sensing and has supervised 20+ graduate students🥼
    • Dr. Easley's lab initially developed blood testing technology for monitoring metabolism markers in animals to understand the biology of diabetes🧬
    • An exclusive license between InnaMed and Auburn was finalized in 2018📝
    • InnaMed has since improved the technology, filing additional patents, improving manufacturability and applying it to human blood samples🩸

Building the Team🧑🏽‍🤝‍🧑🏻

  • After licensing tech, InnaMed hired a key inventor from Dr. Easley's lab👔
  • InnaMed currently has 2 PhDs (from Auburn and Stanford), 2 scientists (from Merck and Adaptimmune), and a skilled mechanical engineer on the team🏢
  • The company is contracting experienced engineers from Bresslergroup and Symbient PD to expedite product development efforts🔨
  • InnaMed has amassed a team of pharma & diagnostics industry advisors and regularly consults with medical, regulatory and manufacturing experts🧰
  • The company has wet/dry lab & offices in Philadelphia with 4 hardware prototype stations, 4 electrochemical test stations and 3 reagent stations🧪

Looking Forward👁️

  • Funding from this round will be used for pilot manufacturing of HomeLab, patient usability studies and hiring additional engineers and scientists 📈

Raise Update - we have raised over $800k on Wefunder & $450k externally.

We are looking to keep the momentum going and hope to reach $1m on Wefunder in the next few weeks. Join us in enabling precision medicine by investing now.